[Treatment of serous and puruloid bronchial hypersecretions in acute and chronic bronchopneumopathies: our experience with a new mucolytic drug].
D000208:Acute Disease; D001982:Bronchial Diseases / Q000188:drug therapy; D002233:Carbocysteine / Q000627:therapeutic use*; D002908:Chronic Disease; D003545:Cysteine / Q000031:analogs & derivatives*; D005100:Expectorants / Q000627:therapeutic use*; D008171:Lung Diseases / Q000188:drug therapy*; D010447:Peptide Hydrolases / Q000627:therapeutic use
D005100:Expectorants; D002233:Carbocysteine; D010447:Peptide Hydrolases; D003545:Cysteine
Contributo al trattamento delle ipersecrezioni bronchiali sierose o puruloidi nelle broncopneumopatie acute e croniche: la nostra esperienza con un nuovo mucolitico